Diagnos Inc (DGNOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104 | 293 | 224 | 489 | 148 |
| Marketable Securities | 224 | 223 | N/A | N/A | N/A |
| Receivables | 95 | 197 | 199 | 305 | 270 |
| TOTAL | $474 | $776 | $435 | $816 | $461 |
| Non-Current Assets | |||||
| PPE Net | 238 | 165 | 188 | 140 | 156 |
| TOTAL | $238 | $165 | $188 | $140 | $156 |
| Total Assets | $712 | $940 | $623 | $955 | $618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 138 | 137 | 128 | 181 | 96 |
| Accounts payable and accrued liabilities | 387 | 358 | 348 | 337 | 407 |
| TOTAL | $603 | $563 | $544 | $574 | $566 |
| Non-Current Liabilities | |||||
| Long Term Debt | 142 | 141 | 154 | 181 | 122 |
| Deferred Revenues | 17 | 7 | 5 | 9 | 13 |
| Other Non-Current Liabilities | 1,846 | 1,831 | 1,283 | 1,228 | 756 |
| TOTAL | $2,160 | $2,071 | $1,553 | $1,501 | $979 |
| Total Liabilities | $2,763 | $2,634 | $2,096 | $2,076 | $1,544 |
| Shareholders' Equity | |||||
| Common Shares | 27,192 | 26,928 | 27,169 | 26,307 | 27,338 |
| Retained earnings | -36,541 | -35,910 | -35,954 | -34,465 | -35,422 |
| Other shareholders' equity | 7,298 | 7,288 | 7,311 | 7,038 | 7,157 |
| TOTAL | $-2,051 | $-1,694 | $-1,474 | $-1,120 | $-927 |
| Total Liabilities And Equity | $712 | $940 | $623 | $955 | $618 |